© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms
July 25, 2025
Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.
Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds
July 25, 2025
Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.
EMA Advisory Group Issues Positive Opinion on Lilly's Donanemab for Treatment of Early Alzheimer Disease
July 25, 2025
The European Commission is expected to make a final regulatory decision on the anti-amyloid therapy in the coming months, Lilly said.
7 Common Causes of Dementia: A Topline Review
July 25, 2025
The brain changes that lead to cognitive and behavioral changes referred to as dementia have multiple potential etiologies; not all dementia is Alzheimer disease.
AI-Generated Dermatologic Images Show Poor Diagnostic Accuracy, Underrepresent Skin of Color
July 25, 2025
In response to the prompt, "Generate a photo of a person with [skin condition]," 3 of 4 generative AI models significantly underrepresented diverse skin tones.
Make It Routine: Screening for Cognitive Decline in Primary Care
July 24, 2025
Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.
Influenza Vaccination Reduces Disease Burden in Both Vaccinated and Unvaccinated, Modeling Study Finds
July 24, 2025
Vaccination lowered influenza cases by about 33% to 42% in seasonal flu setups with 40% vaccine effectiveness, researchers reported.
FDA Grants Fast Track Designation for Sprout's Flibanserin to Treat HSDD in Postmenopausal Women
July 24, 2025
Low sexual desire affects up to 40% of women across the lifespan but currently there is no treatment option for those beyond their reproductive years.
FDA Advisory Panel Calls for Revised Class Labeling for Menopausal Hormone Replacement Therapy
July 24, 2025
Experts reviewed data from the 2002 Women's Health Initiative study that prompted class warnings for estrogen-containing therapies and called for changes, education.
GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes
July 24, 2025
Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.